Ocular Gene Therapy


Ocular gene therapy has made a rapid progress in the past few years. This method directly administered into the eye, targeting diseases caused by mutations in the gene RPE65. Mutations in ths gene can produce Retinitis Pigmentosa, a rare but potentially Blinding diseases.


  • Gene replacement
  • DNA Nanoparticle
  • RNA Interference
  • Ex vivo for Retinal Pigmentosa

Related Conference of Ocular Gene Therapy

February 17-18, 2025

11th Global Ophthalmology Meeting

Amsterdam, Netherlands
February 24-25, 2025

9th World Congress on Eye and Vision

Madrid, Spain
March 17-18, 2025

39th European Ophthalmology Congress

Berlin, Germany
April 07-08, 2025

6th World congress on Ophthalmology and Optometry

Amsterdam, Netherlands
April 29-30, 2025

35th International Congress on Vision Science and Eye

Barcelona, Spain
April 29-30, 2025

6th World Congress on Ophthalmology and Vision Science

Barcelona, Spain
June 12-13, 2025

6th International Conference on Optometry

London, UK
June 17-18, 2025

25th Global Ophthalmologists Annual Meeting

Copenhagen, Denmark

Ocular Gene Therapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in